Primordial

Marijuana and Mental Health

Marijuana and Mental Health is a 2016 book published by the American Psychiatric Association and edited by Michael T. Compton, M.D., M.P.H. The book is a 225-page review of the most recent data about this ubiquitous compound. Following the introductory chapter, the book’s chapters include Marijuana’s Effects on the Mind, Medical and Recreational Marijuana Policy, Medical Marijuana, Marijuana Use and Comorbidity, Marijuana Use and Psychosis, Synthetic Cannabinoids, Treatment of Marijuana Addition, and Prevention of Marijuana Misuse. The book was well written and provides a broad overview of the topics listed above. As the authors clearly and repeatedly point out, as the results of the politics behind this substance, there has been too little research done on the 400 compounds found in marijuana, including about 80 known cannabinoids. One out of 10 marijuana users is likely to become dependent on it, and the percentage is higher among adolescents on whom marijuana impinges on normal neural development. 

If you’re searching for facts to help sort through the other material that you read about marijuana, this book is an excellent place to start. The overall message is that federal policies have limited the good research until now, so it is only now that more facts are becoming known. Although the book does not specifically say this, it is clear that most "medical marijuana" programs are nothing more than a thinly disguised means of smoking recreationally. Where else can you get a "license" without a meaningful medical exam and no follow-up whatsoever by a medical practitioner. It is clear that there is a withdrawal syndrome. Also, about one in 10 adults become dependent, and the rate is higher among teenagers. Also, it is teenagers who have a still developing brain which is most negatively impacted by this substance. 

More facts will emerge in the next 10 years, but be cautious - the facts are not all favorable or even just neutral.

Shrinks: The Untold Story of Psychiatry

Shrinks: The Untold Story of Psychiatry will be of interest to you if you are a psychiatrist and psychoanalyst, like I am, or if you’ve ever been in psychotherapy. The author, Jeffrey Lieberman, M.D., is the Chair of the Department of Psychiatry at Columbia, and he is a recent past president of the American Psychiatric Association. He was the president of the APA when it released its most recent “Bible” of psychiatric diagnoses, the DSM-5, and he is particularly known for his work with schizophrenics. Dr. Lieberman provided a cogent history of psychiatric diagnosis in the U.S. and Europe.

Lieberman concluded with a comment about the value of “pluralism” in psychiatry today, meaning that psychiatrists who operate at the respective poles of biology on the one hand and psychoanalysis on the other, both have something to offer those seeking clinical care today. However, much of his book was an assault on psychoanalysis being an unproven and unscientific theory. In my opinion, some of the attack on analysis was well deserved. Freud predicted that biologic causes and cures would eventually be found for mental illness, but at the time he published The Interpretation of Dreams in 1900, there were no treatments available for the more serious psychiatric diagnoses such as schizophrenia and manic-depressive (bipolar) illness. Such people were simply warehoused in massive state hospitals with no hope of recovery. Some psychiatrists attempted to treat such people with psychoanalysis, and others tried barbaric forms of therapy such as insulin shock, lobotomy, and electroconvulsive shock therapy. Only the later was proven to have some efficacy in some patients. It was not until the 1940s that serendipity led to the discovery of the first effective psychotropic medications, and the evolution of such medications led to the reduction in the huge inpatient populations during the 1950s and 1960s. Meanwhile, the DSM-I was finally published in 1950 as an attempt to have some reliability among the diagnostic language used by psychiatrists. By then, the analysts were in full control of the APA, and it seems most had forgotten Freud’s prediction about finding the biologic underpinnings of the serious illnesses they were trying to treat. It took some decades before the pendulum of power in the APA swung to the biologic side, where it stands at the moment.

There was a time when analysts and biologic psychiatrists could not communicate about their ideas. Analysts saw the others as being barbaric and biologic (or brain-focused) psychiatrists saw analysts as proponents of an unproven and scientifically ungrounded theory. It was not until the DSM-III in 1980 that the brain-focused ones finally expunged analytic theory from the diagnostic language. As a psychiatrist, I found Lieberman’s review of the evolution of our diagnostic language to be fascinating and well-presented.

At the present time, it is clear that psychoanalysis should never have been used to treat the most serious and psychotic illnesses. Certainly analysts brought on some of the eventual enmity they faced by overselling the value of this discipline. But it does remain a treatment of choice for patients with greater ego functioning (and I use the word “ego” in an analytic sense, not as it is used in common day language). Freud did not get everything wrong, and his contributions such as the unconscious mind and transference are critically important to understanding and treating less severely ill patients. However, even when I graduated from a psychoanalytic institute in 1990, some of the senior analysts still bragged that they had never prescribed a single medication to any of their patients. They believed that by prescribing medication, the analyst would be leaving unconscious resistances hidden and untreated. Clearly, those analysts caused harm by eschewing the use of medications that had been proven to have efficacy in depression, mania, and schizophrenia. It was my era of analysts that developed the idea that psychotropic medication and psychoanalysis/psychotherapy were synergistic when used in the right patients, not mutually incompatible. That was a battle that was not easily won.

Lieberman wrote, “The brain is an interface between the ethereal and the organic, where the feelings and memories composing the ineffable fabric of experience are transmuted into molecular biochemistry. Mental illness is a medical condition – but it’s also an existential condition. Within this peculiar duality lies all the historic tumult and future promise of my profession – as well as our species’ consuming fascination with human behavior and mental illness.” Lieberman concluded his book with a remark about an important remaining problem that is faced by psychiatrists and their patients: “Today the single greatest hindrance to treatment is not any gap in scientific knowledge or shortcoming in medical capability but the social stigma. This stigma, unfortunately, has been sustained by the legacy of psychiatry’s historic failures and it enduring reputation – long longer justified – as the unwanted stepchild of medicine.” Well said.